No Detail Found!

Reactivation of hepatitis b virus after covid-19 vaccination. asadullah nawazani

Author(s)
Asadullah Nawazani Benazirabad, sindh Pakistan
Abstract
This case presents a possible vaccine adverse event of reactivation (recurrence) of a dormant hepatitis B infection in a young female patient reported after administering the first dose of Pfizer-BioNTech COVID-19 vaccine. This case aims to explore a potential adverse reaction of COVID-19 mRNA vaccine which can reboot the inactive viruses, in this case of hepatitis B infection, due to immunomodulation leading to decreased alloreactivity after vaccination, as no other trigger or cause was found. A young female with history of inactive hepatitis B infection was admitted in the emergency ward of our Hospital with vomiting, fever, and jaundice after receiving the first dose of Pfizer-BioNTech (NY, NY, USA & Mainz, GY) COVID-19 vaccine. Her blood tests confirmed the resurgence of the acute hepatitis B virus infection and accordingly treated with antiviral Tenofovir and other appropriate supportive management. After clinical improvement and regression of liver function test, she was discharged from the hospital.
Publication Details
Page(s) 184-188
Published Journal: journal of Peoples University of medical and Health Sciences, Pakistan., Volume: 13, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
COVID-19, COVID-19 vaccine, Reactivation, Hepatitis B Infection
0

Citations

0

Downloads

36

Views